SUBSCRIBE
SUBSCRIBE
News   FDA

Health Canada Approves Meridian Bioscience, Inc.'s illumigene C. difficile Molecular Amplification Assay

October 1, 2010 | 
1 min read

MassDevice -- Health Canada grants Meridian Bioscience Inc. an approved medical device license to begin selling the rapid illumigene C. difficile molecular test.

FDA Approvals
MORE ON THIS TOPIC
Pictured: Facade of Moderna's building in Massachusetts
RSV
Moderna’s RSV Vaccines Run Into Safety Roadblock
December 11, 2024
 · 
2 min read
 · 
Tristan Manalac
Mental health, illness ,brain development ,medical treatment concept, messy lines of thinks in human head , vector illustration
Neurodegenerative disease
UniQure Clears Path to Accelerated Approval for Huntington’s Gene Therapy
December 10, 2024
 · 
2 min read
 · 
Tristan Manalac
A scientist with pill bottles in front of FDA headquarters
Regulatory
FDA Action Alert: Ionis, Lexicon, Bristol Myers Squibb and More
December 9, 2024
 · 
7 min read
 · 
Tristan Manalac
Contemporary collage with a running clock and an arrow. Planning and time management concept.
Regulatory
FDA Outlines Accelerated Review Guidelines in Waning Days of Biden Administration
December 6, 2024
 · 
3 min read
 · 
Annalee Armstrong